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https://doi.org/10.1016/j.stemcr.2019.09.002SUMMARYNeuroferritinopathy (NF) is a movement disorder caused by alterations in the L-ferritin gene that generate cytosolic free iron. NF is a
unique pathophysiological model for determining the direct consequences of cell iron dysregulation. We established lines of induced
pluripotent stem cells from fibroblasts from two NF patients and one isogenic control obtained by CRISPR/Cas9 technology. NF fibro-
blasts, neural progenitors, and neurons exhibited the presence of increased cytosolic iron, which was also detectable as: ferritin aggre-
gates, alterations in the iron parameters, oxidative damage, and the onset of a senescence phenotype, particularly severe in the neurons.
In this spontaneous senescencemodel, NF cells had impaired survival and died by ferroptosis. Thus, non-ferritin-bound iron is sufficient
per se to cause both cell senescence and ferroptotic cell death in human fibroblasts and neurons. These results provide strong evidence
supporting the primary role of iron in neuronal aging and degeneration.INTRODUCTION
Neuroferritinopathy (NF) (OMIM, no. 606159) is a rare
dominantly inherited late-onset monogenic disorder
with 100% penetrance caused by mutations in the
L-ferritin gene (FTL1) (Curtis et al., 2001). NF belongs to
a group of monogenic extrapyramidal disorders called neu-
rodegeneration with brain iron accumulation (NBIA) and
is characterized by the focal accumulation of iron in the
basal ganglia (Levi and Finazzi, 2014). The main common
symptoms of NBIA include movement disorders, spas-
ticity, and cognitive impairment; the age of onset varies
among these diseases (Di Meo and Tiranti, 2018), aver-
aging around 40 years. At present, 11 different causative
mutations have been described worldwide, all of which
are located in the last part of exon 4 in the FTL1 sequence
(Levi and Rovida, 2015). These mutations affect both
length and sequence of the C terminus peptide, disturbing
the amino acid contacts involved in the shaping of the hy-
drophobic channels along the 4-fold axis of the molecule
(Levi and Rovida, 2015). In humans, cytosolic ferritin is a
heteropolymeric protein with a spherical shape obtained
by the assembly of 24 structurally similar subunits of two
different types, namely H and L, and encoded by two
genes, FTH1 and FTL1, with iron stored in the internal832 Stem Cell Reports j Vol. 13 j 832–846 j November 12, 2019 j ª 2019 Th
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pression of disease-associated gene variants in vitro (Cozzi
et al., 2010) and in vivo (Maccarinelli et al., 2015; Vidal
et al., 2008) revealed that the NF causative mutations act
in a negative-dominant manner to impair the iron-storage
function of ferritin, resulting in increased level of intracel-
lular free iron (Cozzi et al., 2010; Luscieti et al., 2010).
Emerging evidence supports the key role of iron in aging
(Zecca et al., 2004) and neurodegeneration processes
(Rouault, 2013), mainly because iron accumulates in the
brain during aging (Ward et al., 2014) and its surplus
renders cells more susceptible to oxidative stress (Kosken-
korva-Frank et al., 2013). Thus, NF cellular models repre-
sent valuable tools for investigations of the controversial
role of this metal in the cellular processes occurring during
aging and neurodegeneration. However, the precise role of
iron in the development of these two cellular processes is
not completely elucidated, and its role in the neuronal
compartment is particularly obscure due to the lack of
faithful experimental models recapitulating spontaneous
occurrence of these alterations.
Cellular senescence is normally induced in vitro by
several stressful events (radiation, oxidants, and onco-
genes) and in vivo by ablation of anti-senescent genes,
such as p66 (Berry et al., 2008) and nuclear receptore Author(s).
ecommons.org/licenses/by-nc-nd/4.0/).
co-activator 4 (NCOA4) (Bellelli et al., 2014). Ferroptosis is
prevalently studied in cancer cell lines (Dixon et al., 2012),
where it is revealed only after ferroptosis-inducing reagents
(Xu et al., 2019).
The scarcity of human primary neuronal models to
study the action of iron in aging and neurodegeneration
stimulated us to develop amodel characterized by the pres-
ence of excess free iron. We applied cellular reprogram-
ming techniques (Orellana et al., 2016) to fibroblasts,
obtaining induced pluripotent stem cell (iPSC)-derived
neuronal precursor cells (NPCs) and neurons derived
from two patients affected by NF, one isogenic control
and three healthy subjects. A significant increase of cyto-
solic free iron content, alteration of iron homeostasis,
DNA/protein/lipid oxidative damage, a clear senescence
phenotype, and spontaneous death by ferroptosis were
observed in NF fibroblasts, iPSC-derived NPCs, and neu-
rons compared with controls.
These results, when interpreted in view of the pathoge-
netic mechanism of NF, confirm the detrimental effect of
free iron in neuronal cells. In fact, in conditions such as
NF in which iron is not safely removed from cytosol due
to alterations of ferritin structure/function, it triggers a
cascade of damaging events leading to senescence and fer-
roptosis, thereby accelerating the aging process.RESULTS
Development and Characterization of NF Fibroblasts
and iPSC-Derived Neuronal Models
Fibroblasts were obtained from skin biopsies of two
NF affected patients: one with heterozygous FTL1
469_484dup (Storti et al., 2013), and the other with hetero-
zygous FTL1 351delG_InsTTT (hereafter referred to as NF1
and NF2, respectively) (Figure S1). Control fibroblasts
from three healthy adult subjects were purchased from
ATTC (hereafter referred to as Ctr1, Ctr2, and Ctr3). To
develop a neuronal model we established multiple iPSC
lines by reprogramming fibroblasts from all subjects as pre-
viously described (Orellana et al., 2016). Isogenic control
cells were obtained by CRISPR/Cas9 technology on clone
no. 7 of NF1-iPSC. We used one clone from each healthy
subject (Ctr1 no. 203, Ctr2 no. 37, and Ctr3 no. 151), and
three from each patient and isogenic control (NF1 no. 1,
no. 7, and no. 8; NF2 no. 8, no. 11, and no. 12; and
R-NF1 no. 38, no. 40, and no. 41). Characterization of the
obtained clones of iPSCs, embryoid bodies (EBs), derived
NPCs, and neurons are shown and described in Supple-
mental Information (Figures S2 and S3). Electrophysiolog-
ical recordings in iPSC-derived neurons are reported in Fig-
ure S4. All clones were subjected to the same reported
analysis, an example of which is provided in each panel.NF Fibroblast/iPSC-Derived NPCs and Neurons
Showed Cellular Iron Mobilization and Ferritin/Iron
Aggregates
NFmutations caused structural modification in the ferritin
E-helix, which is involved in the formation of the hydro-
phobic pores of the molecule (Figure S5A) (Cozzi et al.,
2010; Levi and Rovida, 2015). In-silico-generated structural
models of the ferritins containing the mutated subunits
(Figures S5B, S5C, S1B, and S1C) showed the 4-fold channel
dramatically altered, with a larger pore that likely impairs
the retention of iron into the cavity. In theNF2 variant (Fig-
ure S1C), this effect is directly related to the premature stop
site caused by the mutation, resulting in a shortened
sequence and a smaller subunit lacking the E-helix and a
part of the D-helix. In the NF1 variant (Figure S1B), this ef-
fect can be attributed to conformational changes that
expose the E-helix to proteolytic cleavage, as confirmed
experimentally by proteinase K digestion (Figure S1D).
To investigate the ferritin functionality, we treated the fi-
broblasts with 2 mCi 55Fe-ammonium citrate (FeAC) for
18 h. The incorporation of iron into ferritin was reduced
to approximately 20% in the NF1 and NF2 fibroblasts (Fig-
ure S5D) and to 50% in the iPSC-derived neurons (Fig-
ure S5H) compared with controls, probably leaving a
high amount of intracellular free iron. To confirm this ef-
fect, we explored the activity of the IRE/IRP machinery,
which post-transcriptionally controls the expression of
the major iron proteins (ferritin, transferrin receptor 1,
and ferroportin) as a function of cytosolic iron concentra-
tion (Muckenthaler et al., 2008).
ELISA assay, specific for cytosolic ferritin-L (FtL) and
ferritin-H (FtH), performed in fibroblasts, revealed similar
contents of FtL and of FtH among the three controls; in pa-
tients the concentration of FtL was found to be similar to
controls, while FtH was 2-fold higher (Table S1). Immuno-
blotting revealed that the expression of transferrin receptor
1 was decreased 2.5-fold in the NF fibroblasts and NPCs
(Figures S5E and S5F) andwas undetectable in neurons (Fig-
ure S5I); accordingly, ferroportin appeared unchanged in fi-
broblasts (not shown) and NPCs (Figure S5G), and showed
a tendency to increase in neurons (Figure S5L). These data
suggest that the reduced efficiency of iron incorporation of
mutant ferritin results in an increased free cellular iron
availability.
To stress this phenotype, the NF fibroblasts were treated
with 0.1 mM ferric ammonium citrate (FAC) for 14 days
and subjected to immunostaining using an antibody spe-
cific for H-ferritin. The higher number of ferritin-positive
granules observed in the NF1 and NF2 fibroblasts in basal
conditions (Figure 1A, upper panel) was further increased
after treatment with iron (Figure 1A, lower panel). Analysis
at ultrastructural level by electron microscopy (EM) and
electron spectroscopy imaging (ESI) in patient cells showedStem Cell Reports j Vol. 13 j 832–846 j November 12, 2019 833
Figure 1. Representative Images of NF Fibroblasts and iPSC-Derived Neurons Showed Formation of Ferritin/Iron Aggregates
(A) Control and variant fibroblasts untreated (UT) or treated (Fe) with 100 mM FeAC for 14 days and stained with an anti-human H-ferritin
antibody (Hoechst staining to detect the nuclei). The arrows show the ferritin aggregates. Scale bars, 20 mm.
(B) Ultrastructural analysis of fibroblasts examined under an electron microscope (EM). The arrows indicate the aggregates. Cells untreated
(UT) or treated (Fe) as described in (A) were subjected to an ESI analysis. The images showing the ultrastructural organization observed at
250 eV with a superimposed iron map represented by pseudo-colors. The iron granules were counted and are represented as a ratio to the
total number in the counted fields (means ± SD of three independent experiments). The data were analyzed by unpaired, two-tailed t test,
***p < 0.001.
(legend continued on next page)
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that the granules were localized in the cytosol, mainly
associated with lipid droplets and surrounded by bilayer
membranous formations (Figure 1B), similarly to the ones
detected in the NF disease mouse model (Maccarinelli
et al., 2015). ESI defined iron as a component of these ag-
gregates (Figure 1B), the number of which was 3-fold
greater in NF than in control cells.
A similar phenotype was present in the NF iPSC-derived
neurons. Immunofluorescence analysis on NF iPSC-
derived neurons showed increased FtH, visualized as gran-
ular formations localized to the cytosolic part of the soma
and along the axon (Figure 1C). These formations were
also detectable by Perls staining (a specific dye for ferric
iron deposits), suggesting the presence of a large amount
of iron (Figure 1D). A 3-week treatment with the iron
chelator deferoxamine (DFO) (5 mM) and the antioxidant
n-acetyl-cysteine (NAC) (100 mM) reverted this phenotype
(Figures 1C and 1D).
Cellular Iron Mobilization-Induced Oxidative
Damage and Cellular Death in the NF Fibroblast/iPSC-
Derived NPCs and Neurons
The free redox-active form of iron promotes the formation
of free oxygen/nitrogen radicals, and thus increased
cellular iron availability may affect cell resistance to oxida-
tive stress. We searched for any sign of an altered cellular
oxidative status under basal conditions and compared
NF fibroblasts, iPSC-derived NPCs, and neurons with con-
trols. For each cell type, we set up appropriate methods to
reveal different types of oxidative damage products. The
ROS levels were assayed by the specific fluorescent probe
20,70-dichlorofluorescein (DCF). Carbonylated proteins
were assessed using an Oxy-Blot analysis, while lipid per-
oxidation was assessed using an Oxy-MDA assay (Cozzi
et al., 2010) and C11-Bodipy (581/591) staining. A low
but significant increase in the ROS levels was revealed in
the NF fibroblasts (Figure 2A), which was corroborated
by an enhancement of oxidized proteins in NF fibroblasts,
iPSC-derived NPCs, and neurons (Figures 2B, 2D, and 2F).
Lipid peroxidation was significantly increased only in the
NF1, but not NF2, fibroblasts (Figure 2C); however, the
phenotype was more severe in the NPCs and neurons,
and the cells from both patients showed a statistically
significant difference from the controls (Figures 2E and
2G). Furthermore, the reduced form of glutathione was
significantly decreased in the NF iPSC-derived neurons
(Figure 2H).(C) Immunofluorescence of b-III-tubulin (Tuj1) and H-ferritin (FtH) in
staining for the nuclei), and co-treatment with the iron chelator (5 mM
of images (dashed rectangles) is shown. Scale bars, 20 mm.
(D) Control and NF1 Perls staining under basal conditions and after
presence of iron aggregates. Scale bars, 20 mm.To investigate whether this altered oxidative status was
sufficient to promote cellular death, we performed DAPI
and trypan blue staining and LDH determination. No sig-
nificant differences were detected between controls and
NF fibroblasts (not shown), indicating that the NF fibro-
blasts did not die by apoptosis or necrosis. However, the
MTT assay revealed a significantly decreased number of
viable cells in the NF fibroblasts (NF1 27%, NF2
22%), which was more consistent in the iPSC-derived
NPCs (NF1 46%, NF2 52%) and neurons (NF1 52%,
NF2 51%) compared with the controls. To confirm the
specific involvement of free iron in eliciting cell death,
neurons were grown for 3 weeks in the presence of the
iron chelator deferiprone (5 mM) (Pinto et al., 2018). The
addition of deferiprone prevented the death of the
NF-derived neurons (90% NF1 and 94% NF2 viable
cells), demonstrating that iron is the leading cause of
neuronal death.
Iron-Induced Senescence in NF Fibroblast/iPSC-
Derived NPCs and Neurons
Patient fibroblasts showed a disorganized layer that did not
reach cellular confluence in the plate/flask (Figure 3A,
bright field), suggesting the presence of a senescence
phenotype in these cells. We stained the cells to detect
SA-b-galactosidase (SA-b-Gal) activity at pH 6. In control
cells this activity was almost undetectable, while NF fibro-
blasts showed positive staining that boosted in intensity as
the cell passages increased (not shown); in particular, at the
13th passage the SA-b-Gal-positive cells constituted 90%
of all NF1 and 60% of all NF2 fibroblasts versus 10% of all
controls (Figure 3A).
To investigate whether the increased cytosolic free iron
availability was the primary cause of the cellular
senescence, we treated fibroblasts at an intermediate
passage (i.e., the fifth passage) with 500 mM FAC for
24 h and analyzed their morphology and SA-b-Gal activ-
ity. The NF1 fibroblasts showed an evident change in
morphology and a 30% increase of SA-b-Gal activity
compared with the untreated cells, while control cells
were almost unaffected (Figure 3B). When the iron
treatment was performed in the presence of 500 mM
NAC for 24 h, the cellular morphology and SA-b-Gal ac-
tivity of the NF1 fibroblasts were similar to those of the
untreated cells (Figure 3B), implying that the antioxidant
treatment was able to counteract the effect of iron
supplementation.neurons obtained from a control subject and patient NF1 (Hoechst
DFO) and antioxidant (100 mM NAC). Digital higher-magnification
treatment with 5 mM DFO and 100 mM NAC. The arrows show the
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Figure 2. Cellular Iron Mobilization-Induced Oxidative Damage in NF Fibroblast/iPSC-Derived NPCs and Neurons
(A) Fibroblasts were incubated with the ROS-sensitive 20,70-dichlorofluorescein. The results are presented as the mean of three inde-
pendent experiments in octuplicate.
(B and C) Quantification by densitometry of Oxyblot (B) and lipid-malondialdehyde (MDA) peroxidation (C) of fibroblasts.
(D and E) Quantification of Oxyblot (D) and lipid-MDA peroxidation (E) of NPCs.
(F) Oxyblot of neurons.
(G) BODIPY of neurons.
(H) Glutathione (GSH)-sensitive ThiolTracker Violet fluorescence signal detected on Tuj1-positive human neurons.
The data are presented as the means ± SD (B–F) or ± SEM (G and H) of at least three independent experiments. All the data were analyzed
by unpaired, two-tailed t test, *p < 0.05, **p < 0.01, ***p < 0.001.Ultrastructural analysis of NF fibroblasts showed vacu-
olar formations, similar to those already detected in senes-
cent cells (Malatesta et al., 2011), which were almost836 Stem Cell Reports j Vol. 13 j 832–846 j November 12, 2019undetectable in the control cells (Figure 3C, upper panel).
EM analysis did not show alterations in the mitochondria
ultrastructure in the NFs fibroblasts (Figure 3C, lower
Figure 3. Iron-Induced Senescence in NF Fibroblasts
(A and B) (A) Cells morphology (upper panel) and SA-b-Gal activity (lower panel) in bright field. Scale bars, 20 mm. (B) SA-b-Gal activity of
NF1 cells treated with iron (Fe) and NAC. Scale bars, 20 mm. Positive stained cells in (A) and (B) were counted and plotted as a percentage
of the total cells. The results are presented as the mean ± SD of five fields in three independent experiments.
(legend continued on next page)
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Figure 4. Iron-Induced Senescence in NF
iPSC-Derived NPCs and Neurons
(A and B) (A) SA-b-Gal activity in NPCs. Scale
bars, 20 mm. (B) SA-b-Gal activity in neu-
rons. Scale bars, 20 mm. Positive stained
cells in (A) and (B) were counted and plotted
as a percentage of the total cells. The results
are presented as the mean ± SD of five fields
in three independent experiments.
(C) Immunoblotting of p62 expression in
soluble neuron homogenates. Load repre-
sents Coomassie blue staining. Results are
presented as the mean ± SD of three inde-
pendent experiments. The data were
analyzed by unpaired, two-tailed t test, *p <
0.05, **p < 0.01, ***p < 0.001.panel), suggesting that mitochondria function was not
impaired in this cellular model. However, we cannot
exclude mitochondrial impairment in neurons differenti-
ated for longer time.
The NF fibroblasts showed a 3- to 4-fold increase in the
LC3II protein compared with the controls (Figure 3D). In
addition, the content of interleukin-1b (IL-1b) was signifi-
cantly increased in both NF1 and NF2. The amount of
IL-6 appeared extremely high only in NF1 (Figure 3E),
while IL-8 and tumor necrosis factor alpha were(C) Ultrastructural analysis of fibroblasts examined by EM evidencing
(D) Immunoblotting of LC3I and II expression in soluble fibroblast h
dependent experiments.
(E) Levels of IL-1b and IL-6 determined by ELISAs on cell media. The
periments in octuplicate. The data were analyzed by unpaired, two-ta
0.05, **p < 0.01, ***p < 0.001.
838 Stem Cell Reports j Vol. 13 j 832–846 j November 12, 2019unchanged. All these interleukins were undetectable in
growth media from the iPSC-derived NPCs and neurons
(not shown).
Interestingly, analysis of SA-b-Gal activity revealed a
high number of positive cells in NF1 and NF2 iPSC-
derived NPCs and neurons, reaching 70% and 20% in
NF1 and NF2 NPCs, respectively (Figure 4A), and above
70% in neurons of both patients (Figure 4B). Moreover,
the analysis of p62 expression (Masaldan et al., 2018)
confirmed the increase of this peptide in neurons fromvacuoles (white arrows) and mitochondria (black arrows).
omogenates. Results are presented as the mean ± SD of three in-
results are presented as the mean ± SD of three independent ex-
iled t test, except for (B) in which one-way ANOVA were used, *p <
(legend on next page)
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both patients (Figure 4C), further proving the cellular
senescence status.
Iron-Dependent Senescence Phenotype Involves a
NCOA4 Decrease and p53 Activation
NCOA4 is a mediator of ferritinophagy (Mancias et al.,
2014) and is involved in senescence (Bellelli et al., 2014).
We analyzed its expression in NF fibroblasts and NPCs to
investigate the origin of the senescence phenotype. In
the NF fibroblasts, the level of the NCOA4 protein was sub-
stantially undetectable (Figure 5A), although the level of
NCOA4-mRNA was not significantly changed compared
with the controls (Figure 5D). A similar result was obtained
in the control cells exposed to 100 mM FeAC (Figure 5B),
suggesting that the addition of iron to cells mimics the ef-
fect of the increased free cytosolic iron caused by ferritin
dysfunction and is sufficient to stimulate NCOA4 degrada-
tion. The addition of the protease inhibitor leupeptin
(50 mM) to inhibit the lysosomal enzymatic activity re-
sulted in an increased amount of NCOA4 in the NF fibro-
blasts (Figure 5C).
The iPSC-derived NPCs and neurons from the controls
showed a low level of NCOA4 expression, which was
further reduced in the patients’ cells (Figures 5E–5G). One
of the main roles of NCOA4 is to maintain DNA stability
(Bellelli et al., 2014); thus, we investigated DNA damage
by testing the presence of correlated post-translational his-
tone modifications. Immunoblotting analysis showed a
large increase in Ser139 phosphorylation on g-H2A.X his-
tone in the NF neurons compared with a negligible level
in the control cells (Figure 5H), suggesting that the telo-
mere uncapping starts to support the initiation of the
dsDNA break response (d’Adda di Fagagna et al., 2003).
In addition, the immunofluorescence staining revealed
that a massive decrease in NCOA4 was concurrent with
the translocation of p53 to the nucleus in the NF-derived
NPCs (Figure 5F). To determine whether p53 also acquires
its transcriptional activity in iPSC-derived neurons, we
evaluated the transcription of one of its target genes,
i.e., SLC7A11, a key component of the cystine/glutamateFigure 5. Iron-Dependent Senescence Phenotype Involves an NCO
(A–C) Immunoblotting of NCOA4 expression in soluble fibroblast homo
results are presented as the mean ± SD of three independent experim
(D) NCOA4 mRNA levels of fibroblasts determined by qRT-PCR and norm
the mean ± SD of three independent experiments.
(E) Immunoblotting of NCOA4 expression in soluble NPC homogenate
three independent experiments.
(F) Immunofluorescence of p53 and NCOA4 in NPCs. The results are pr
bars, 20 mm.
(G and H) Immunoblotting of NCOA4 expression (G) and H2A.X (H) in
(I) qRT-PCR analysis of SLC7A11 expression. The data are presented a
The data were analyzed by unpaired, two-tailed t test, **p < 0.01, **
840 Stem Cell Reports j Vol. 13 j 832–846 j November 12, 2019antiporter. In the patient neurons, the amount of
SLC7A11 mRNA was increased by 6-fold (Figure 5I).
Overall, these data suggest that the NF fibroblasts, iPSC-
derived NPCs, and neurons exhibited a consistent senes-
cent phenotype in multiple aspects, and that this cellular
status was associated with the activation of the p53-signal-
ling pathway.
Iron Triggers Cell Death via Ferroptosis in iPSC-
Derived Neurons
p53 has been described as an activator of ferroptosis, thus
the p53-nuclear translocation is suggestive of a possible
pathway of cellular death via ferroptosis (Jiang et al.,
2015). iPSC-derived NPCs were incubated with 80 mM era-
stin for 18 h in the presence or not of 20 mM ferrostatin-1.
Cell viability was then evaluated by an MTT assay (Fig-
ure 6A). The data suggested that erastin reduced the cell
viability to 50% in the isogenic control and 25% in the
NFs (Figure 6A). Ferrostatin-1 rescued the viability of the
cells (Figure 6A), suggesting that ferroptosis is crucially
involved in the cell death program. To confirm the hypoth-
esis that cytosolic iron mobilization triggers ferroptosis,
iPSC-derived NPCs and neurons were grown in the pres-
ence of ferrostatin-1 (2.6 mM for five passages and 1 mM
for 3 weeks, respectively). Then, we performed the MTT
analysis in the absence of erastin. A reduction in cell
viability was observed in the NF cells compared with their
isogenic counterparts and was comparable with the reduc-
tion observed in the erastin-treated isogenic control (Fig-
ures 6A and 6B). The addition of ferrostatin-1 did not affect
the isogenic control cells but was able to significantly pre-
vent cell death in the NF NPCs and neurons, indicating
that cytosolic iron mobilization is sufficient to cause cell
death via ferroptosis (Figures 6B and 6C).
Furthermore, from the above experiments that were per-
formed in parallel starting from the same cell number we
calculated the percentage of neurons that died by ferropto-
sis and those in senescence (Figure 6D). We found that the
percentage of senescent cells was higher than the b-galacto-
sidase-negative cells (73% versus 27% in NF1 and 67%A4 Decrease and p53 Activation
genates, untreated (A), treated with iron (B), or leupeptin (C). The
ents.
alized to the mRNA expression of GAPDH. The data are presented as
s, * unspecific band. The results are presented as the mean ± SD of
esented as the mean ± SD of three independent experiments. Scale
neuron soluble homogenates, * unspecific band.
s the mean ± SD values of three independent experiments.
*p < 0.001.
Figure 6. Iron Triggers Cell Death via
Ferroptosis in iPSC-Derived NPCs and
Neurons
(A) MTT assay of NPCs treated with/without
80 mM of erastin and 20 mM of ferrostatin-1
for 18 h.
(B) NPCs re-plated for five passages in the
presence of 2.6 mM ferrostatin-1.
(C) Neurons treated with 1 mM ferrostatin-1
during differentiation.
(D) Scheme representing the percentage of
senescent and ferroptotic cells in neurons.
All results are presented as a percentage of
cell viability compared with that in the
isogenic controls and as the mean ± SD of
three independent experiments. The data
were analyzed by unpaired, two-tailed t test,
**p < 0.01, ***p < 0.001.versus 33% in NF2), while in ferroptotic cells we reported a
lower percentage compared with the viable cells (43%
versus 57% in NF1 and 42% versus 58% in NF2). Thus,
the number of ferroptotic cells is higher than non-senes-
cent (negative) cells (Figure 6D), indicating that the differ-
encemay be attributed to a portion of senescent cells dying
by ferroptosis.DISCUSSION
Using cell-reprogramming technology, we clarified the
pathogenesis of NF in an in vitro human neuronal model
and outlined the molecular mechanism by which iron
plays a primary role in triggering the cascade of events
that leads to neuronal death. The defective ferritin shell
promotes redox-active iron excess in the cytosol, thereby
inducing (1) the upregulation of iron-dependent ferritin
translation, which generates the continuous overproduc-
tion of defective peptides and facilitates ferritin aggrega-
tion; (2) a decrease in NCOA4 that reduces ferritinophagy
favors ferritin/iron aggregation, and implements DNAinstability; and (3) an increase in ROS, causing oxidative
injury followed by DNA damage and protein and lipid
oxidation. As a consequence, the cells either activate path-
ways leading to senescence (possibly as a defensive mecha-
nism) or, alternatively, have an increased tendency to die
by ferroptosis (Figure 7).
The appearance of an evident senescence phenotype in
the fibroblasts demonstrated that free iron alone may
induce a cell-cycle arrest to counteract iron imbalance.
This phenotype is even more pronounced in NF neurons,
indicating that even quiescent cells can activate cell-cy-
cle-associated events in response to DNA damage (Kruman
et al., 2004). Thus, these results provide strong evidence
supporting the direct involvement of iron in the aging pro-
cess, especially in the neuronal compartment, as demon-
strated by iron accumulation in the brain during both
physiological and pathological aging (Ward et al., 2014).
The precise mechanism of regulation of iron uptake into
the brain is currently not fully defined; however, growing
evidence suggests that, during aging, the blood-brain bar-
rier becomes more permeable to iron, thus favoring its
deposition (Marques et al., 2013). It is conceivable that,Stem Cell Reports j Vol. 13 j 832–846 j November 12, 2019 841
Figure 7. Scheme of the Proposed Molecu-
lar Mechanism Stimulated by Iron in NF
and Aging
The insertion of the variant L-ferritin pep-
tide into the protein shell causes the
enhancement of redox-active iron in the
cytosol, inducing iron-dependent ferritin
translation that generates the over-
production of protein, facilitating its ag-
gregation. Furthermore, an iron-dependent
decrease in NCOA4 occurs that abolishes the
physiological degradation of ferritin by the
lysosome, further increasing ferritin/iron
aggregation. The augmentation of ROS pro-
motes cell oxidative injury with consequent
DNA damage and protein and lipid oxidation.
DNA instability is also enhanced by the
diminished level of NCOA4. The cells seem to
respond by triggering a p53-dependent
pathway that further promotes senescence.
However, the endless ROS-induced lipid
peroxidation leads to death by ferroptosis.
Although over a much longer time course, this mechanism might also occur physiologically during aging due to the ferritin/iron accu-
mulation mainly in non-dividing cells.in neuronal cells, when accumulated iron exceeds the abil-
ity of ferritin to incorporate it, an iron-dependent detri-
mental process is triggered, leading to cell aging (Figure 7).
Although with a premature onset and higher severity, a
similar chain of events is initiated in the disease state as
shown here in NF.
The molecular mechanism responsible for triggering
senescence in these cellular models appeared to be medi-
ated by the iron-dependent reduction of the ferritin-cargo
NCOA4, which, in addition to failing to maintain ferriti-
nophagy (Mancias et al., 2015), induced ferritin accumula-
tion and facilitated DNA instability. In fact, NCOA4 also
acts as a regulator of DNA stability as demonstrated in
Ncoa4/ MEFs in which Ncoa4 ablation caused aberrant
DNA replication origin activation, generating replication
stress and premature senescence (Bellelli et al., 2014). In
addition, the iron-dependent development of ROS exacer-
bates DNA instability as confirmed by the increased Ser139
phosphorylation on the H2A.X histone (Burma et al.,
2001). Cells appeared to respond to the insult by activating
the p53-dependent anti-cellular stress pathway, as demon-
strated by the p53-nuclear translocation and the increase in
its transcriptional activity in neurons. This latter result
seems contradictory because, recently, the tumor-suppres-
sion activity of p53 has been reported to be involved in
the regulation of cystine metabolism, and p53 exerts its ef-
fect by repressing the expression of SLC7A11 and inducing
ferroptosis (Jiang et al., 2015). However, previous studies
investigating mouse models have suggested that iron
excess might negatively regulate p53 signaling by both842 Stem Cell Reports j Vol. 13 j 832–846 j November 12, 2019destabilizing the p53 protein and interfering with its
DNA binding activity (Shen et al., 2014). Thus, we cannot
exclude the possibility that p53 might progressively lose
its ability to protect cells. Indeed, p53 accumulation has
been detected in autoptic NF brain samples as a component
of the protein aggregates that are pathognomonic of the
disease (Curtis et al., 2001).
Remarkably, in our cellular models, ferroptosis can also
occur in senescent cells. In fact, in the NF-derived NPCs
and neurons, the development of senescence occurred in
parallel with consistent cellular death, which was signifi-
cantly reduced by ferrostatin-1, a widely used inhibitor
of ferroptosis. Moreover, we can formulate some hypothe-
ses about the fate of senescent cells among non-dividing
cells, such as neurons. By simultaneously measuring senes-
cence and ferroptosis in parallel experiments, we noticed
that the percentage of senescent iPSC-derived neurons is
higher than that in neurons that did not die by ferroptosis.
This finding implies that at least some neurons showed a
senescence phenotype before ferroptotic death. This
intriguing result might be explained by considering that
senescence and ferroptosis are not induced by other acti-
vating agents but instead develop consecutively over a
relatively long period. Moreover, this study is the first
work reporting a simultaneous analysis of senescence
and ferroptosis in human neurons, highlighting a peculiar
behavior of neuronal cells. It is well known that neuronal
cells are more sensitive to iron toxicity than MEFs or can-
cer cell lines generally used in these experiments (Stock-
well et al., 2017). Thus, the development of ferroptosis
soon after senescence can be a peculiarity of this cell type.
Alternatively, the continuous cellular deterioration due to
the excess of cytoplasmic free iron counteracts the ability
of neurons to maintain the senescence status, leading to
premature death. Although the present in vitro experi-
mental model does not include all cellular types that are
involved in iron management in the nervous system,
such as the glial components, we believe that it represents
an innovative and valid approach to study the direct
involvement of iron in neurodegenerative processes. In
fact, even in this simplified model we have been able to
detect iron accumulation in human NF neurons, similarly
to that occurring in patients, and thus we show that iron
triggers neuronal death via ferroptosis.
In summary, we demonstrated that non-ferritin-bound
iron is able to cause both cell senescence and ferroptotic
cell death in human fibroblasts and neurons, indicating
a primary role of iron in accelerating the processes of ag-
ing and neurodegeneration. These data have also impor-
tant implications for studies investigating the role of
iron in a more general context of neurodegenerative dis-
eases. The pathogenetic mechanism that we described in
the setting of NF might be common in various neurode-
generative disorders, such as Alzheimer (Liu et al.,
2018), Parkinson (McLeary et al., 2019), and Huntington
diseases (Mi et al., 2019), amyotrophic lateral sclerosis (Yu
et al., 2019), and frontotemporal lobar dementia (Zhang
et al., 2017), in which dysfunction of the lysosome-auto-
phagy pathway can lead to ferritin engulfment with
consequent impairment of iron homeostasis (Biasiotto
et al., 2016). Accordingly, growing evidence suggests
that iron imbalance is a hallmark of neurodegenerative
diseases, suggesting that iron chelators may be therapeu-
tic options for preventing these diseases (Ward et al.,
2014). Our data support this idea and suggest considering
the monitoring of iron deposition in the brain during ag-
ing and carefully evaluating iron-supplemented diets in
elderly people.EXPERIMENTAL PROCEDURES
The primary fibroblast cell lines were generated from skin biopsies
from two patients, obtained with informed consent from the pa-
tients, and three healthy adult subjects purchased from ATCC.Cases
The case of the patient carrying the FTL1 469_484dup mutation
(named NF1) has been described previously (Storti et al., 2013).
The second patient carrying the heterozygous nucleotide inser-
tion 351delG_InsTTT in FTL1 (namedNF2) is a 58-year-oldwoman
who presented with mild tremor in both hands at the age of
52 years. The patient did not exhibit alterations in muscular
tone or an unsteady gait with broadened and multidirectionalretropulsion after the pushing test without spontaneous rest. No
optical alterations were observed. The neuropsychological evalua-
tion showed moderate cognitive deterioration. These symptoms
appearedwithin a fewweekswith progressiveworsening.No famil-
iarity was present. The laboratory examinations showed normal
vitamin B12 values and hepatic and renal function parameters. A
low level of serum ferritin (1.1 ng/mL, normal range 15–
150 ng/mL) and normal saturated transferrin and sideremia values
were obtained. Brain MRI showed hyperintensity with surround-
ing hypointensity on T2*-weighted imaging involving the pal-
lidum, substantia nigra, and red nucleus. The clinical symptoms,
radiological evidence, and low level of serum ferritin suggested
an analysis of the FTL1 gene; the DNA sequence identified the
abovementioned mutation associated with NF.iPSC Generation
The fibroblasts were grown in DMEM (Invitrogen) supplemented
with 10% fetal bovine serum (Invitrogen), 100 mg/mL strepto-
mycin, 100 U/mL penicillin and 2 mM L-glutamine (Sigma-Al-
drich) and reprogrammed into iPSCs as in (Orellana et al., 2016)
using CytoTune-iPS 2.0 Sendai reprogramming kit (Life Technolo-
gies) according to the manufacturer’s instructions. Colonies
started to appear 30 days later, and on approximately day 40, the
cells were selected according to their morphology and transferred
to a new feeder layer in DMEM/F12 (Sigma-Aldrich), 20%
knockout serum replacement (Life Technologies), 1% penicillin/
streptomycin (P/S), 2 mM L-glutamine, 1% non-essential amino
acids MEM NEAA (Life Technologies), 1 mM NaPyr (Sigma-Al-
drich), 0.1 mM b-mercaptoethanol (Life Technologies), and
10 ng/mL fibroblast growth factor 2 (FGF2) (Life Technologies).
Subsequently, the iPSC clones were passed into feeder-free condi-
tions on Matrigel hESC-qualified coated plates (Corning) while
gradually increasing the percentage of Essential 8 medium (Life
Technologies). The iPSCs were passaged every 5–7 days with
ReLeSR (STEMCELLTechnologies) onMatrigel-coatedwells. The fi-
broblasts and iPSCs were periodically tested for mycoplasma
contamination by PCR. To detect the presence of FTL1 mutations
in the iPSCs clones, the genomic DNA was amplified by PCR, and
the purified PCR products were analyzed by Sanger sequencing
(GATC Biotech). The DNA sequences of the primers are listed in
Table S2 (primers designated P1Fw and Re were used for the
sequencing of the NF1 and R-NF1 clones, and P2 Fw and Re were
used for the sequencing of theNF2 clones). In vitro three germ layer
differentiation and karyotype analysis were performed as in Orel-
lana et al. (2016).Generation of R-NF1 Clones
We performed a gene knockin of the FTL1 WT allele in the NF1
iPSCs by combining CRISPR/Cas9 with a single-stranded oligo-
deoxynucleotide donor template and an sgRNA directed specif-
ically to the 469_484dup mutation as listed in Table S2. The gene
correction was corroborated by a sequence analysis of the iPSC
clones. The potential off-target sites were selected according to
http://crispr.mit.edu. We analyzed the seven most likely off-target
hits present in the gene coding regions as described previously (Ru-
bio et al., 2016). These sites were amplified by genomic PCR using
the following primers: DPF1 Fw, DPF1 Re, ACADS Fw, ACADS Re,Stem Cell Reports j Vol. 13 j 832–846 j November 12, 2019 843
TUBB4 Fw, TUBB4 Re, SUZ12 Fw, SUZ12 Re, GPR150 Fw, GPR150
Re, FTL 2 Fw, FTL 2 Re, METTL25 Fw, and METTL25 Re (Table
S2). Then, we performed Sanger sequencing.
Generation of Human NPCs and Neurons
The NPCs and EBs were formed by the dissociation of the iPSC col-
onies following the procedure described in (Orellana et al., 2016).
To obtain the rosettes, the EBs were plated onto Matrigel growth
factor reduced (Corning)-coated dishes in DMEM/F12 (Sigma-Al-
drich) plus N2 (1:200), 1% NEAA (Life Technologies), and 1% P/S
(Marchetto et al., 2010). After 10 days, the rosettes were dissociated
with accutase and plated again onto Matrigel-coated dishes with
the NPC medium DMEM/F12, N2 (1:200), B27 (1:100, Life Tech-
nologies), 1% P/S, and FGF2 (20 ng/mL). Homogeneous NPC pop-
ulations were achieved after 3–5 passages with accutase under the
same conditions. The neurons were obtained as described previ-
ously (Orellana et al., 2016). The NPCs were transduced with a
lentivirus-expressing Ngn2 cDNA under the control of the tetracy-
cline-responsive promoter TetO-Ngn2-t2a-Puro (kindly provided
by T.C. Sudhof) and a lentivirus-expressing rtTA. The lentiviruses
were produced as described previously (Indrigo et al., 2010). The
NPCs were seeded on Matrigel-coated wells and differentiated in
medium containing Neurobasal (Life Technologies), BDNF
(10 ng/mL, Peprotech), NT-3 (10 ng/mL, Peprotech), B27, P/S,
glutamine, and doxycycline (2 mg/mL, Sigma-Aldrich). NT-3 was
present in the medium only during the first week of differentia-
tion, and doxycycline was present only for 3 weeks. Half of theme-
dium was changed every 2–3 days.
Electrophysiology
Whole-cell patch-clamp recordings were performed after 45 days
of differentiation. Cells were continuously perfused with standard
artificial cerebrospinal fluid containing the following (inmM): 125
NaCl, 2.5 KCl, 25 NaHCO3, 2 CaCl2, 1 MgCl2, 1.25 NaH2PO4, and
11 glucose bubbled with 95% O2 and 5% CO2 at pH 7.3 at room
temperature. Glass pipettes were filled with a solution containing
the following (in mM): 124 KH2PO4, 2 MgCl2, 10 NaCl, 10 HEPES,
0.5 EGTA, 2 Na2-ATP, and 0.02 Na-GTP (pH 7.2, adjusted with
KOH; tip resistance, 5–6 MU). Action potential firing was evoked
in current clamp mode by current injection steps (10–50 pA,
500ms). Traces were recorded using a digital amplifier (Multiclamp
700B, Molecular Devices) interfaced with a PC through an analog-
to-digital board (Digidata 1440A, Molecular Devices). Signals were
acquired and analyzed using pClamp software (Molecular De-
vices). All reagents were supplied by Sigma-Aldrich.
Iron Parameter Analysis and Immunofluorescence
Cellular 55Fe incorporation, EM, ESI, ferritin quantification, iron-
protein expression, analysis of cellular oxidative status, and immu-
nofluorescence staining were described previously (Cozzi et al.,
2010; Maccarinelli et al., 2015; Orellana et al., 2016). The used an-
tibodies were listed in Table S3.
Cell Viability Assay
In total, 2 3 104 cells grown at 37C in the appropriate medium
were treated with or without deferiprone, erastin, or ferrostatin
at the concentrations and times indicated in the figure legends844 Stem Cell Reports j Vol. 13 j 832–846 j November 12, 2019and finally incubated with 10 mL MTT solution (5 mg/mL in phos-
phate-buffered saline) for 2 h at 37C. The color absorbance was
read at 570 nm following the manufacturer’s instructions (Sigma-
Aldrich) (Cozzi et al., 2010).
SA-b-Gal Activity Detection
The cells were analyzed according to the protocol ‘‘Senescence
Cells Histochemical Staining’’ (Sigma). This assay is based on a his-
tochemical stain for b-galactosidase activity at pH 6. In brief, the
cells were fixed with a solution containing 20% formaldehyde
and 2% glutaraldehyde, stained with a solution of X-gal, and incu-
bated at 37C for 18h. The cells were also treatedwith 0.5mMFAC,
0.5mMNAC, and 0.1mMDFO for 18 h, and b-galactosidase activ-
ity was analyzed as described above. The cells were observed under
bright light; the blue-stained cells and total number of cells were
counted, and the percentage of cells expressing b-galactosidase
was calculated.
qRT-PCR Analysis
RNA was extracted using an RNeasy kit (QIAGEN) and then retro-
transcribed using a High Capacity cDNA Reverse Transcription Kit
(Applied Biosystems). For the real-time qPCR analysis, HOT
FIREPol EvaGreen qPCR Mix Plus (Solis Biodyne) was used, and
the expression levels were normalized to GAPDH expression. The
primers specific for SLC7A11 and NCOA4 are listed in Table S2.
Computational Analysis
The secondary and tertiary structure information of wild-type
ferritin was obtained fromX-ray coordinates of the human ferritin
L chain (PDB: 2FFX). For the mutants, the secondary structure pre-
diction was performed with the online tool ‘‘Psi-pred’’ (http://
bioinf.cs.ucl.ac.uk/psipred/), while the 3D structure was modeled
with a threading approach using the iTasser server (https://
zhanglab.ccmb.med.umich.edu/I-TASSER/). The electrostatic po-
tential was calculated with Delphi software package using the
default parameters (Li et al., 2012). The surface representation of
the electrostatic potential was obtained with PyMol Molecular
Graphics System (Schrödinger), which was also used for all molec-
ular visualizations.
Statistical Analyses
Statistical methods were not employed to predetermine sample
size in the in vitro experiments. All the experiments were per-
formed at least in triplicate; data were analyzed using GraphPad
Prism. In general, for normally distributed data two-tailed un-
paired Student’s t test and one-wayANOVA followed by Bonferroni
post-test was used. Data are reported as means ± SD or ± SEM. A p
value < 0.05 was considered statistically significant.
SUPPLEMENTAL INFORMATION
Supplemental Information can be found online at https://doi.org/
10.1016/j.stemcr.2019.09.002.
AUTHOR CONTRIBUTIONS
A.C., D.I.O., A.R., and C.C. developed the neuronal models and
maintained iPSCs. A.C. and D.I.O. performed in vitro analysis.
P.S. performed biochemical analysis. M.R. performed electrophys-
iological recordings. S.G. performed the CRISPR/Cas9 gene correc-
tion. E.R. performed molecular modeling. G.D.L. measured
interleukin levels. M.F. provided the genetic analysis of iPSCs.
G.L.F. and C.F. provided fibroblasts from patients. S.T. analyzed
electrophysiological data and wrote the manuscript. V.B. super-
vised iPSC and gene editing work and collaborate to write the
manuscript. S.L. conceived the study and wrote the manuscript.
All authors have given their approval of the final version of the
manuscript.
ACKNOWLEDGMENTS
A part of this work was carried out at ALEMBIC, which is an
advanced microscopy laboratory established by the San Raffaele
Scientific Institute and the Vita-Salute San Raffaele University.
The authors are grateful to Filippo Santorelli and Alessandra
Tessa, Molecular Medicine Lab, IRCCS Stella Maris, for caring
for the patients and providing the skin biopsies, and to Eufemia
Putortı̀ for the graphical assistance in drawing the scheme
showed in Figure 7. Deferiprone was kindly provided by Dr. Fer-
nando Tricta, ApoPharma, Toronto, Canada. The financial sup-
port from Telethon-Italia (grant nos. GGP10099, GGP11088,
and GGP16234 to S.L.), AISNAF (to S.L.), and the European
Research Council (AdERC no. 340527 to V.B.) is gratefully
acknowledged.
Received: April 19, 2019
Revised: September 5, 2019
Accepted: September 5, 2019
Published: October 3, 2019REFERENCES
Arosio, P., and Levi, S. (2010). Cytosolic and mitochondrial ferri-
tins in the regulation of cellular iron homeostasis and oxidative
damage. Biochim. Biophys. Acta 1800, 783–792.
Bellelli, R., Castellone, M.D., Guida, T., Limongello, R., Dathan,
N.A., Merolla, F., Cirafici, A.M., Affuso, A., Masai, H., Costanzo,
V., et al. (2014). NCOA4 transcriptional coactivator inhibits activa-
tion of DNA replication origins. Mol. Cell 55, 123–137.
Berry, A., Greco, A., Giorgio,M., Pelicci, P.G., de Kloet, R., Alleva, E.,
Minghetti, L., and Cirulli, F. (2008). Deletion of the lifespan deter-
minant p66(Shc) improves performance in a spatial memory task,
decreases levels of oxidative stress markers in the hippocampus
and increases levels of the neurotrophin BDNF in adult mice.
Exp. Gerontol. 43, 200–208.
Biasiotto, G., Di Lorenzo, D., Archetti, S., and Zanella, I. (2016).
Iron and neurodegeneration: is ferritinophagy the link? Mol. Neu-
robiol. 53, 5542–5574.
Burma, S., Chen, B.P., Murphy, M., Kurimasa, A., and Chen, D.J.
(2001). ATM phosphorylates histone H2AX in response to DNA
double-strand breaks. J. Biol. Chem. 276, 42462–42467.
Cozzi, A., Rovelli, E., Frizzale, G., Campanella, A., Amendola, M.,
Arosio, P., and Levi, S. (2010). Oxidative stress and cell death in
cells expressing L-ferritin variants causing neuroferritinopathy.
Neurobiol. Dis. 37, 77–85.Curtis, A.R., Fey, C., Morris, C.M., Bindoff, L.A., Ince, P.G., Chin-
nery, P.F., Coulthard, A., Jackson, M.J., Jackson, A.P., McHale,
D.P., et al. (2001). Mutation in the gene encoding ferritin light
polypeptide causes dominant adult-onset basal ganglia disease.
Nat. Genet. 28, 350–354.
d’Adda di Fagagna, F., Reaper, P.M., Clay-Farrace, L., Fiegle, R.H.,
Carr, P., Von Zglinicki, T., Saretzki, G., Carter, N.P., and Jackson,
S.P. (2003). A DNA damage checkpoint response in telomere-initi-
ated senescence. Nature 426, 194–198.
Di Meo, I., and Tiranti, V. (2018). Classification and molecular
pathogenesis of NBIA syndromes. Eur. J. Paediatr. Neurol. 22,
272–284.
Dixon, S.J., Lemberg, K.M., Lamprecht, M.R., Skouta, R., Zaitsev,
E.M., Gleason, C.E., Patel, D.N., Bauer, A.J., Cantley, A.M., Yang,
W.S., et al. (2012). Ferroptosis: an iron-dependent form of nona-
poptotic cell death. Cell 149, 1060–1072.
Indrigo, M., Papale, A., Orellana, D., and Brambilla, R. (2010). Len-
tiviral vectors to study the differential function of ERK1 and ERK2
MAP kinases. Methods Mol. Biol. 661, 205–220.
Jiang, L., Kon, N., Li, T., Wang, S.J., Su, T., Hibshoosh, H., Baer, R.,
and Gu, W. (2015). Ferroptosis as a p53-mediated activity during
tumour suppression. Nature 520, 57–62.
Koskenkorva-Frank, T.S., Weiss, G., Koppenol, W.H., and Burck-
hardt, S. (2013). The complex interplay of iron metabolism, reac-
tive oxygen species, and reactive nitrogen species: insights into
the potential of various iron therapies to induce oxidative and ni-
trosative stress. Free Radic. Biol. Med. 65, 1174–1194.
Kruman, I.I., Wersto, R.P., Cardozo-Pelaez, F., Smilenov, L., Chan,
S.L., Chrest, F.J., Emokpae, R., Jr., Gorospe, M., and Mattson, M.P.
(2004). Cell cycle activation linked to neuronal cell death initiated
by DNA damage. Neuron 41, 549–561.
Levi, S., and Finazzi, D. (2014). Neurodegeneration with brain iron
accumulation: update on pathogenicmechanisms. Front. Pharma-
col. 5, 99.
Levi, S., and Rovida, E. (2015). Neuroferritinopathy: from ferritin
structure modification to pathogenetic mechanism. Neurobiol.
Dis. 81, 134–143.
Li, L., Li, C., Sarkar, S., Zhang, J., Witham, S., Zhang, Z., Wang, L.,
Smith, N., Petukh,M., andAlexov, E. (2012). DelPhi: a comprehen-
sive suite for DelPhi software and associated resources. BMC Bio-
phys. 5, 9.
Liu, J.L., Fan, Y.G., Yang, Z.S., Wang, Z.Y., and Guo, C. (2018). Iron
and Alzheimer’s disease: frompathogenesis to therapeutic implica-
tions. Front. Neurosci. 12, 632.
Luscieti, S., Santambrogio, P., Langlois d’Estaintot, B., Granier, T.,
Cozzi, A., Poli, M., Gallois, B., Finazzi, D., Cattaneo, A., Levi, S.,
et al. (2010). Mutant ferritin L-chains that cause neurodegenera-
tion act in a dominant-negative manner to reduce ferritin iron
incorporation. J. Biol. Chem. 285, 11948–11957.
Maccarinelli, F., Pagani, A., Cozzi, A., Codazzi, F., Di Giacomo, G.,
Capoccia, S., Rapino, S., Finazzi, D., Politi, L.S., Cirulli, F., et al.
(2015). A novel neuroferritinopathymouse model (FTL 498InsTC)
shows progressive brain iron dysregulation,morphological signs of
early neurodegeneration and motor coordination deficits. Neuro-
biol. Dis. 81, 119–133.Stem Cell Reports j Vol. 13 j 832–846 j November 12, 2019 845
Malatesta,M., Giagnacovo,M., Renna, L.V., Cardani, R., Meola, G.,
and Pellicciari, C. (2011). Cultured myoblasts from patients
affected by myotonic dystrophy type 2 exhibit senescence-related
features: ultrastructural evidence. Eur. J. Histochem. 55, e26.
Mancias, J.D., Pontano Vaites, L., Nissim, S., Biancu, R.D.E., Kim,
A.J., Wang, X., Liu, Y., Goessling, W., Kimmelman, A.C., and
Harpe, R.J.W. (2015). Ferritinophagy via NCOA4 is required for
erythropoiesis and is regulated by iron dependent HERC2-medi-
ated proteolysis. Elife 4, e10308.
Mancias, J.D., Wang, X., Gygi, S.P., Harper, J.W., and Kimmelman,
A.C. (2014). Quantitative proteomics identifies NCOA4 as the
cargo receptor mediating ferritinophagy. Nature 509, 105–109.
Marchetto,M.C., Carromeu, C., Acab, A., Yu, D., Yeo, G.W., Mu, Y.,
Chen, G., Gage, F.H., and Muotri, A.R. (2010). A model for neural
development and treatment of Rett syndrome using human
induced pluripotent stem cells. Cell 143, 527–539.
Marques, F., Sousa, J.C., Sousa, N., and Palha, J.A. (2013). Blood-
brain-barriers in aging and in Alzheimer’s disease.Mol. Neurodege-
ner. 8, 38.
Masaldan, S., Clatworthy, S.A.S., Gamell, C., Meggyesy, P.M., Rigo-
poulos, A.T., Haupt, S., Haupt, Y., Denoyer, D., Adlard, P.A., Bush,
A.I., et al. (2018). Iron accumulation in senescent cells is coupled
with impaired ferritinophagy and inhibition of ferroptosis. Redox
Biol. 14, 100–115.
McLeary, F.A., Rcom-H’cheo-Gauthier, A.N., Goulding, M., Rad-
ford, R.A.W., Okita, Y., Faller, P., Chung, R.S., and Pountney, D.L.
(2019). Switching on endogenous binding proteins in Parkinsons’s
disease cell. Cells 8, 179.
Mi, Y., Gao, X., Xu, H., Cui, Y., Zhang, Y., and Gou, X. (2019). The
emerging roles of ferroptosis inHuntington’s disease. Neuromolec-
ular. Med. 21, 110–111.
Muckenthaler, M.U., Galy, B., and Hentze, M.W. (2008). Systemic
iron homeostasis and the iron-responsive element/iron-regulatory
protein (IRE/IRP) regulatory network. Annu. Rev. Nutr. 28,
197–213.
Orellana, D.I., Santambrogio, P., Rubio, A., Yekhlef, L., Cancellieri,
C., Dusi, S., Giannelli, S.G., Venco, P.,Mazzara, P.G., Cozzi, A., et al.
(2016). Coenzyme A corrects pathological defects in human neu-
rons of PANK2-associated neurodegeneration. EMBO Mol. Med.
8, 1197–1211.
Pinto, V.M., Balocco, M., Quintino, S., Bacigalupo, L., Gianesin, B.,
Rizzi, M., Malago, R., De Franceschi, L., and Forni, G.L. (2018).
Daily alternating deferasirox and deferiprone therapy successfully
controls iron accumulation in untreatable transfusion-dependent
thalassemia patients. Am. J. Hematol. 93, E79–E82.846 Stem Cell Reports j Vol. 13 j 832–846 j November 12, 2019Rouault, T.A. (2013). Ironmetabolism in the CNS: implications for
neurodegenerative diseases. Nat. Rev. Neurosci. 14, 551–564.
Rubio, A., Luoni, M., Giannelli, S.G., Radice, I., Iannielli, A., Can-
cellieri, C., Di Berardino, C., Regalia, G., Lazzari, G., Menegon,
A., et al. (2016). Rapid and efficient CRISPR/Cas9 gene inactivation
in human neurons during human pluripotent stem cell differenti-
ation and direct reprogramming. Sci. Rep. 6, 37540.
Shen, Y., Zhang, S., Huang, X., Chen, K., Shen, J., and Wang, Z.
(2014). Involvement of p53 mutation and mismatch repair pro-
teins dysregulation in NNK-induced malignant transformation of
human bronchial epithelial cells. Biomed. Res. Int. 2014, 920275.
Stockwell, B.R., Friedmann Angeli, J.P., Bayir, H., Bush, A.I., Con-
rad, M., Dixon, S.J., Fulda, S., Gascon, S., Hatzios, S.K., Kagan,
V.E., et al. (2017). Ferroptosis: a regulated cell death nexus linking
metabolism, redox biology, and disease. Cell 171, 273–285.
Storti, E., Cortese, F., Di Fabio, R., Fiorillo, C., Pierallini, A., Tessa,
A., Valleriani, A., Pierelli, F., Santorelli, F.M., and Casali, C.
(2013). De novo FTL mutation: a clinical, neuroimaging, and mo-
lecular study. Mov. Disord. 28, 252–253.
Vidal, R., Miravalle, L., Gao, X., Barbeito, A.G., Baraibar, M.A., Hek-
matyar, S.K., Widel, M., Bansal, N., Delisle, M.B., and Ghetti, B.
(2008). Expression of a mutant form of the ferritin light chain
gene induces neurodegeneration and iron overload in transgenic
mice. J. Neurosci. 28, 60–67.
Ward, R.J., Zucca, F.A., Duyn, J.H., Crichton, R.R., and Zecca, L.
(2014). The role of iron in brain ageing and neurodegenerative dis-
orders. Lancet Neurol. 13, 1045–1060.
Xu, T., Ding, W., Ji, X., Ao, X., Liu, Y., Yu, W., andWang, J. (2019).
Molecularmechanisms of ferroptosis and its role in cancer therapy.
J. Cell Mol. Med. 23, 4900–4912.
Yu, J.,Wang, N., Qi, F.,Wang, X., Zhu, Q., Lu, Y., Zhang, H., Che, F.,
and Li,W. (2019). Serum ferritin is a candidate biomarker of disease
aggravation in amyotrophic lateral sclerosis. Biomed. Rep. 9,
333–338.
Zecca, L., Youdim, M.B., Riederer, P., Connor, J.R., and Crichton,
R.R. (2004). Iron, brain ageing and neurodegenerative disorders.
Nat. Rev. Neurosci. 5, 863–873.
Zhang, Y., Schmid, B., Nikolaisen, N.K., Rasmussen, M.A., Aldana,
B.I., Agger, M., Calloe, K., Stummann, T.C., Larsen, H.M., Nielsen,
T.T., et al. (2017). Patient iPSC-derived neurons for disease
modeling of frontotemporal dementia withmutation in CHMP2B.
Stem Cell Reports 14, 648–658.
